{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T19:44:59Z","timestamp":1773431099714,"version":"3.50.1"},"reference-count":34,"publisher":"JLE","issue":"6","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Dermatol"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1684\/ejd.2018.3446","type":"journal-article","created":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T15:21:09Z","timestamp":1696864869000},"page":"795-802","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["The burden of chronic spontaneous urticaria: unsatisfactory treatment and healthcare resource utilization in France (the ASSURE-CSU study)"],"prefix":"10.1684","volume":"28","author":[{"given":"Jean-Philippe","family":"Lacour","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdallah","family":"Khemis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7oise","family":"Giordano-Labadie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ludovic","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Delphine","family":"Staumont-Salle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florence","family":"Hacard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haijun","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doreen","family":"McBride","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly","family":"Hollis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shannon","family":"Hunter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurent","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Audrey","family":"Lamirand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Le Guen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria-Magdalena","family":"Balp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Berard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"18929","published-online":{"date-parts":[[2019,5,6]]},"reference":[{"key":"3446_CR1","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.pop.2015.08.002","volume":"42","author":"L Jafilan","year":"2015","unstructured":"Jafilan L, James C. Urticaria and allergy-mediated conditions. Prim Care Clin Office Pract 2015; 42: 473\u201383.","journal-title":"Prim Care Clin Office Pract"},{"key":"3446_CR2","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1097\/00130832-200310000-00008","volume":"3","author":"MW Greaves","year":"2003","unstructured":"Greaves MW. Chronic idiopathic urticaria. Curr Opin Allergy Clin Immunol 2003; 3: 363\u20138.","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"3446_CR3","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1111\/all.12313","volume":"69","author":"T Zuberbier","year":"2014","unstructured":"Zuberbier T, Aberer W, Asero R, et al. The EAACI\/GA(2) LEN\/EDF\/WAO guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update. Allergy 2014; 69: 868\u201387.","journal-title":"Allergy"},{"key":"3446_CR4","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/j.1398-9995.2010.02496.x","volume":"66","author":"M Maurer","year":"2011","unstructured":"Maurer M, Weller K, Bindslev-Jensen C, et al. Unmet clinical needs in chronic spontaneous urticaria. A GA(2)LEN Task Force Report. Allergy 2011; 66: 317\u201330.","journal-title":"Allergy"},{"key":"3446_CR5","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/jdv.13198","volume":"29","author":"M Maurer","year":"2015","unstructured":"Maurer M, Church MK, Goncalo M, Sussman G, Sanchez-Borges M. Management and treatment of chronic urticaria (CU). J Eur Acad Dermatol Venereol 2015; 29: 16\u201332.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3446_CR6","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1111\/bjd.14768","volume":"175","author":"S Guill\u00e9n-Aguinaga","year":"2016","unstructured":"Guill\u00e9n-Aguinaga S, J\u00e1uregui Presa I, Aguinaga-Ontoso E, Guill\u00e9n-Grima F, Ferrer M. Updosing nonsedating antihistamines in patients with chronic spontaneous urticaria: a systematic review and metaanalysis. Br J Dermatol 2016; 175: 1153\u201365.","journal-title":"Br J Dermatol"},{"key":"3446_CR7","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.anai.2015.06.030","volume":"115","author":"J Vietri","year":"2015","unstructured":"Vietri J, Turner SJ, Tian H, Isherwood G, Balp MM, Gabriel S. Effect of chronic urticaria on US patients: analysis of the National Health and Wellness Survey. Ann Allergy Asthma Immunol 2015; 115: 306\u201311.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"3446_CR8","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s40271-015-0145-9","volume":"8","author":"MM Balp","year":"2015","unstructured":"Balp MM, Vietri J, Tian H, Isherwood G. The impact of chronic urticaria from the patient\u2019s perspective: a survey in five European countries. Patient 2015; 8: 551\u20138.","journal-title":"Patient"},{"key":"3446_CR9","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/j.1365-2133.1997.tb14895.x","volume":"136","author":"BF O\u2019Donnell","year":"1997","unstructured":"O\u2019Donnell BF, Lawlor F, Simpson J, Morgan M, Greaves MW. The impact of chronic urticaria on the quality of life. Br J Dermatol 1997; 136: 197\u2013201.","journal-title":"Br J Dermatol"},{"key":"3446_CR10","doi-asserted-by":"publisher","first-page":"3187","DOI":"10.1038\/jid.2015.330","volume":"135","author":"G Shalom","year":"2015","unstructured":"Shalom G, Linder D, Comaneshter D, et al. Healthcare services utilization and drug use in patients with chronic urticaria. J Invest Dermatol 2015; 135: 3187\u20139.","journal-title":"J Invest Dermatol"},{"key":"3446_CR11","doi-asserted-by":"publisher","first-page":"4","DOI":"10.2500\/aap.2014.35.3713","volume":"35","author":"D Weldon","year":"2014","unstructured":"Weldon D. Quality of life in patients with urticaria and angioedema: assessing burden of disease. Allergy Asthma Proc 2014; 35: 4\u20139.","journal-title":"Allergy Asthma Proc"},{"key":"3446_CR12","first-page":"152","volume":"70","author":"C Thenie","year":"2015","unstructured":"Thenie C, Amsler E, Augustin M, Pinton P. Prevalence, patients\u2019 profiles and management in chronic spontaneous urticaria \u2014 the ETNA study. Allergy 2015; 70: 152.","journal-title":"Allergy"},{"key":"3446_CR13","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13601-015-0072-9","volume":"5","author":"K Weller","year":"2015","unstructured":"Weller K, Maurer M, Grattan C, et al. ASSURE-CSU: a real-world study of burden of disease in patients with symptomatic chronic spontaneous urticaria. Clin Transl Allergy 2015; 5: 29.","journal-title":"Clin Transl Allergy"},{"key":"3446_CR14","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1111\/all.13209","volume":"72","author":"M Maurer","year":"2017","unstructured":"Maurer M, Abuzakouk M, Berard F, et al. The burden of chronic spontaneous urticaria is substantial: real-world evidence from ASSURECSU. Allergy 2017; 72: 2005\u201316.","journal-title":"Allergy"},{"key":"3446_CR15","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1111\/j.1398-9995.2009.02178.x","volume":"64","author":"T Zuberbier","year":"2009","unstructured":"Zuberbier T, Asero R, Bindslev-Jensen C, et al. EAACI\/GA(2)LEN\/EDF\/WAO guideline: management of urticaria. Allergy 2009; 64: 1427\u201343.","journal-title":"Allergy"},{"key":"3446_CR16","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1111\/j.1398-9995.2008.01726.x","volume":"63","author":"A Mlynek","year":"2008","unstructured":"Mlynek A, Zalewska-Janowska A, Martus P, Staubach P, Zuberbier T, Maurer M. How to assess disease activity in patients with chronic urticaria? Allergy 2008; 63: 777\u201380.","journal-title":"Allergy"},{"key":"3446_CR17","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1111\/j.1398-9995.2005.00833.x","volume":"60","author":"I Baiardini","year":"2005","unstructured":"Baiardini I, Pasquali M, Braido F, et al. A new tool to evaluate the impact of chronic urticaria on quality of life: chronic urticaria quality of life questionnaire (CU-QoL). Allergy 2005; 60: 1073\u20138.","journal-title":"Allergy"},{"key":"3446_CR18","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","volume":"19","author":"AY Finlay","year":"1994","unstructured":"Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI) \u2014 a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210\u20136.","journal-title":"Clin Exp Dermatol"},{"key":"3446_CR19","volume-title":"Work productivity and activity impairment questionnaire","author":"MC Reilly","year":"2004","unstructured":"Reilly MC. Work productivity and activity impairment questionnaire, 2004, Available from: http:\/\/www.reillyassociates.net\/Index.html."},{"key":"3446_CR20","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1524-4733.2009.00663.x","volume":"13","author":"JW Hay","year":"2010","unstructured":"Hay JW, Smeeding J, Carroll NV, et al. Good research practices for measuring drug costs in cost effectiveness analyses: issues and recommendations: the ISPOR Drug Cost Task Force Report \u2014 Part I. Value Health 2010; 13: 3\u20137.","journal-title":"Value Health"},{"key":"3446_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2165\/00019053-199813010-00001","volume":"13","author":"B Liljas","year":"1998","unstructured":"Liljas B. How to calculate indirect costs in economic evaluations. Pharmacoeconomics 1998; 13: 1\u20137.","journal-title":"Pharmacoeconomics"},{"key":"3446_CR22","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/j.1346-8138.2007.00276.x","volume":"34","author":"K Kulthanan","year":"2007","unstructured":"Kulthanan K, Jiamton S, Thumpimukvatana N, Pinkaew S. Chronic idiopathic urticaria: prevalence and clinical course. J Dermatol 2007; 34: 294\u2013301.","journal-title":"J Dermatol"},{"key":"3446_CR23","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/jid.2014.306","volume":"135","author":"SS Saini","year":"2015","unstructured":"Saini SS, Bindslev-Jensen C, Maurer M, et al. Efficacy and safety of omalizumab in patients with chronic idiopathic\/spontaneous urticaria who remain symptomatic on H1 antihistamines: a randomized, placebo-controlled study. J Invest Dermatol 2015; 135: 67\u201375.","journal-title":"J Invest Dermatol"},{"key":"3446_CR24","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jaci.2013.05.013","volume":"132","author":"A Kaplan","year":"2013","unstructured":"Kaplan A, Ledford D, Ashby M, et al. Omalizumab in patients with symptomatic chronic idiopathic\/spontaneous urticaria despite standard combination therapy. J Allergy Clin Immunol 2013; 132: 101\u20139.","journal-title":"J Allergy Clin Immunol"},{"key":"3446_CR25","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1056\/NEJMoa1215372","volume":"368","author":"M Maurer","year":"2013","unstructured":"Maurer M, Rosen K, Hsieh HJ, et al. Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria. N Engl J Med 2013; 368: 924\u201335.","journal-title":"N Engl J Med"},{"key":"3446_CR26","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1111\/j.1365-2230.2010.03840.x","volume":"35","author":"T Zuberbier","year":"2010","unstructured":"Zuberbier T, Balke M, Worm M, Edenharter G, Maurer M. Epidemiology of urticaria: a representative cross-sectional population survey. Clin Exp Dermatol 2010; 35: 869\u201373.","journal-title":"Clin Exp Dermatol"},{"key":"3446_CR27","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s40257-015-0134-8","volume":"16","author":"MS Broder","year":"2015","unstructured":"Broder MS, Raimundo K, Antonova E, Chang E. Resource use and costs in an insured population of patients with chronic idio-pathic\/spontaneous urticaria. Am J Clin Dermatol 2015; 16: 313\u201321.","journal-title":"Am J Clin Dermatol"},{"key":"3446_CR28","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.anai.2011.10.018","volume":"108","author":"JL Zazzali","year":"2012","unstructured":"Zazzali JL, Broder MS, Chang E, Chiu MW, Hogan DJ. Cost, utilization, and patterns of medication use associated with chronic idiopathic urticaria. Ann Allergy Asthma Immunol 2012; 108: 98\u2013102.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"3446_CR29","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1016\/j.jaci.2012.01.043","volume":"129","author":"R Confino-Cohen","year":"2012","unstructured":"Confino-Cohen R, Chodick G, Shalev V, Leshno M, Kimhi O, Goldberg A. Chronic urticaria and autoimmunity: associations found in a large population study. J Allergy Clin Immunol 2012; 129: 1307\u201313.","journal-title":"J Allergy Clin Immunol"},{"key":"3446_CR30","volume-title":"\u00c9tat des connaissances sur l\u2019impact sanitaire li\u00e9 \u00e0 l\u2019exposition de la population g\u00e9n\u00e9rale aux pollens pr\u00e9sents dans l\u2019air ambiant. Rapport d\u2019expertise collective","author":"Agence nationale de s\u00e9curit\u00e9 sanitaire de l\u2019alimentation, de l\u2019environnement et du travail ANSES","year":"2014","unstructured":"Agence nationale de s\u00e9curit\u00e9 sanitaire de l\u2019alimentation, de l\u2019environnement et du travail (ANSES). \u00c9tat des connaissances sur l\u2019impact sanitaire li\u00e9 \u00e0 l\u2019exposition de la population g\u00e9n\u00e9rale aux pollens pr\u00e9sents dans l\u2019air ambiant. Rapport d\u2019expertise collective. Agence nationale de s\u00e9curit\u00e9 sanitaire de l\u2019alimentation, de l\u2019environnement et du travail (ANSES), 2014."},{"key":"3446_CR31","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1111\/all.12007","volume":"67","author":"K Weller","year":"2012","unstructured":"Weller K, Groffik A, Magerl M, et al. Development and construct validation of the angioedema quality of life questionnaire. Allergy 2012; 67: 1289\u201398.","journal-title":"Allergy"},{"key":"3446_CR32","first-page":"210","volume":"46","author":"M Sanchez-Borges","year":"2014","unstructured":"Sanchez-Borges M, Caballero-Fonseca F, Capriles-Hulett A. Subtypes of chronic urticaria in patients attending allergy clinics in Venezuela. Eur Ann Allergy Clin Immunol 2014; 46: 210\u20135.","journal-title":"Eur Ann Allergy Clin Immunol"},{"key":"3446_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2165\/00044011-200626010-00001","volume":"26","author":"A Kapp","year":"2006","unstructured":"Kapp A, Demarteau N. Cost effectiveness of levocetirizine in chronic idiopathic urticaria: a pooled analysis of two randomised controlled trials. Clin Drug Investig 2006; 26: 1\u201311.","journal-title":"Clin Drug Investig"},{"key":"3446_CR34","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.1365-2133.2005.06385.x","volume":"152","author":"JJ Grob","year":"2005","unstructured":"Grob JJ, Revuz J, Ortonne JP, Auquier P, Lorette G. Comparative study of the impact of chronic urticaria, psoriasis and atopic dermatitis on the quality of life. Br J Dermatol 2005; 152: 289\u201395.","journal-title":"Br J Dermatol"}],"container-title":["European Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1684\/ejd.2018.3446.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1684\/ejd.2018.3446\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1684\/ejd.2018.3446.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.jle.com\/10.1684\/ejd.2018.3446","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T16:17:41Z","timestamp":1741191461000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jle.com\/10.1684\/ejd.2018.3446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["3446"],"URL":"https:\/\/doi.org\/10.1684\/ejd.2018.3446","relation":{},"ISSN":["1952-4013"],"issn-type":[{"value":"1952-4013","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"29 M\u00e4rz 2018","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 Mai 2019","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}